http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016153365-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79b1d5347904d176fc381f429861fdb3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-8895
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-38
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-882
filingDate 2016-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a40fdfd6252c1ff8f3f3da30241b9a11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccae884cdc92caedf4b72704fbe89d08
publicationDate 2016-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2016153365-A1
titleOfInvention Naturally-derived compositions from calamus ornatus for anti-inflammatory applications
abstract This invention pertains to derivatives of Calamus ornatus extracts and pure compound derivatives consistent with spirostanol saponins as selective inhibitors of cyclooxygenase 2 (COX-2). Activation of COX-2 is implicated with intense inflammation and pain, as well as other biological processes such as oncogenesis, angiogenesis and even for bowel movement. Hence, such activity of the compositions against COX-2 makes it a promising anti-inflammatory agent. With its different structure from the traditional COX-2 inhibitors, as well as the use of the source plant as a traditional food source, it is also likely that the invention might be safer to use, acutely or chronically.
priorityDate 2015-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005089419-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005112218-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID156391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395832
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395293
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406619
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395645
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5090
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226461989
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2662
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID99474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5312542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396627
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123619
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406377
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395154
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3715

Total number of triples: 51.